cytovale Multicenter Study Shows Reproducible Clinical and Operational Gains Following Expansion of IntelliSep Sepsis Test Across Health System PR Newswire 2026.03.23
cytovale Cytovale’s IntelliSep® Named Modern Healthcare’s Best in Business for Second Consecutive Year PR Newswire 2026.01.12
cytovale Rapid Sepsis Test Reduces Mortality, Shortens Hospital Stay Infectious Disease Special Edition 2025.12.29
cytovale New Data Reveals Path to SEP-1 Success Includes Early Sepsis Risk Stratification PR Newswire 2025.09.07
cytovale Cytovale’s Rapid Sepsis Test Drives 56% Increase in ED Discharges Without Compromise to Patient Safety, Study Finds PR Newswire 2025.07.29
cytovale Cytovale’s Rapid Diagnostic Slashes Sepsis Mortality by 39%, Peer-Reviewed Study Confirms BioSpace 2025.06.13
cytovale Accelerated Demand for Cytovale’s FDA-Cleared Sepsis Detection Solution, IntelliSep®, to Drive Growth in 2025 PR Newswire 2025.01.09
cytovale Cytovale Recognized as One of Modern Healthcare’s 2024 Best in Business PR Newswire 2024.12.09
cytovale Cytovale’s FDA-Cleared Sepsis Diagnostic Triages First 5,000 Patients, Paves Way to New Hospital Protocols for Sepsis Management BioSpace 2024.06.20
cytovale Cytovale’s sepsis diagnostic test demonstrates 97.5% NPV in latest study ClinicalTrials Arena 2024.05.03
cytovale Cytovale’s Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application PR Newswire 2024.03.19
cytovale BARDA announces clinical studies of host-based diagnostics to demonstrate impact in improving patient care Medical Countermeasures.gov 2024.02.06
cytovale New Study Underscores Need for Greater Objectivity and Speed in Sepsis Diagnosis and Triage PR Newswire 2023.12.06
cytovale Cytovale collects $84M to roll out its rapid ER sepsis diagnostic test FIERCE Biotech 2023.11.16
cytovale IntelliSep Sepsis Test Could Save Money and Patient Lives INSIDE PRECISION MEDICINE 2023.09.27
